Topics

Civetta Therapeutics, LLC Company Profile

11:38 EST 14th December 2019 | BioPortfolio

Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of developing important therapeutics for cancers and other diseases. For more information, please visit www.civettatherapeutics.com.


News Articles [837 Associated News Articles listed on BioPortfolio]

$53M added to Civetta's funds to advance propeller protein studies

Civetta Therapeutics raised $53 million through a Series A funding round that will support the development of cancer drugs th -More- 

Civetta Therapeutics closes $53mm Series A round

Civetta Therapeutics LLC (beta-propeller domain drug targets) raised $53mm in its Series A round from Deerfield Management.

Civetta Therapeutics Unveils a Propeller Protein Plan, $53M in Funding

New biotech company Civetta Therapeutics has closed a $53 million Series A financing round to develop drugs that target “propeller proteins” as a way of treating cancers and other diseases. Propel...

Civetta starts operations with know-how licenses from Broad Institute and Dana-Farber

Civetta Therapeutics LLC received know-how licenses from the Broad Institute and Dana-Farber Cancer Institute to advance its research into beta-propeller domain drug targets.

Civetta Therapeutics Announces $53 million Series A to Advance Lead Programs and Develop Proprietary Platform Targeting Propeller Proteins

Civetta Therapeutics is a Deerfield founded and funded company Civetta Therapeutics, LLC announced a $53 million Series A financing to advance select programs and a proprietary platform focused on b...

CRISPR Therapeutics Takes Over Joint Venture Casebia Therapeutics from Bayer

LEVERKUSEN, Germany and ZUG, Switzerland and CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ — CRISPR Therapeutics and Bayer today announced proposed plans whereby Casebia Therapeutics, a joint ven...

Proteon Therapeutics to merge with ArTara Therapeutics

Proteon Therapeutics, which focuses on kidney and vascular diseases, has signed a definitive agreement to merge with rare and speciality...Read More... The post Proteon Therapeutics to merge with ArTa...

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

Clover Therapeutics, which sprung out of Clover Health, is supported by a number of biotech and pharma veterans, including Pfizer veteran Cheng Zhang, who is heading up therapeutics, and Genentech vet...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [441 Associated PubMed Articles listed on BioPortfolio]

Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke.

Digital therapeutics is an evidence-based intervention using high-quality software, with the sole purpose of treatment. As many healthcare systems are encountering high demands of quality outcomes, th...

Measurement of mRNA therapeutics: method development and validation challenges.

The progression of chemically modified mRNA therapeutics through development pipelines is accelerating for many disease indications and the need to assess these analytes is becoming more routine for t...

Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.

From Engineered Tissues and Microfludics to Human Eyes-On-A-Chip.

Antiglaucoma EP Agonists: A Long Road That Led Somewhere.

For >2 decades, EP agonists have been the subject of antiglaucoma research and development by scientists in industry and academia around the world. The road has led to the recent approval of the first...

Clinical Trials [200 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1400 Associated Companies listed on BioPortfolio]

Civetta Therapeutics, LLC

Civetta is a Cambridge, MA based cancer therapeutics company, founded to advance new medicines through small molecule targeting of beta-propeller domains with the goal of developing important therape...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

Click Therapeutics, Inc.

Click Therapeutics, Inc. engineers, validates, and commercializes Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavi...

More Information about "Civetta Therapeutics, LLC" on BioPortfolio

We have published hundreds of Civetta Therapeutics, LLC news stories on BioPortfolio along with dozens of Civetta Therapeutics, LLC Clinical Trials and PubMed Articles about Civetta Therapeutics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Civetta Therapeutics, LLC Companies in our database. You can also find out about relevant Civetta Therapeutics, LLC Drugs and Medications on this site too.

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record